Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms

Arquivos de Neuro-Psiquiatria

Volumn 64, Issue 4, 2006, Pages 941-945

  Da Silva, Vanessa Cavalcante ^a   Ramos, Flávio José Da Costa ^a   Freitas, Elizabete Malaquias ^a   De Brito Marques, Paulo Roberto ^a   Cavalcanti, Márcia Nery De Holanda ^a   D'Almeida, Vânia ^b   Cabral Filho, José Eulálio ^c   Muniz, Maria Tereza Cartaxo ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c INSTITUTO DE MEDICINA INTEGRAL PROF FERNANDO FIGUEIRA   (Brazil)

Author keywords

Alzheimer's disease; Homocysteine; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ALZHEIMER DISEASE; ARTICLE; BRAZIL; CLINICAL ARTICLE; CLINICAL FEATURE; COFFEE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ELDERLY CARE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; RISK ASSESSMENT;

EID: 33846310455     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2006000600010     Document Type: Article

References (33)

1. Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Gen 1994;7:195-200.
2. Van der Put NMJ, Gabreels F, Stevens EMB, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-1051.
3. Kang SS, Zhou J, Wong PWK, et al. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 1988;43:414-421.
4. Andreassi MG, Botto N, Battaglia FCD, et al. Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease. Hum Genet 2003;112:171-177.
5. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71(Suppl):S621-S629.
6. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 1993;76:460-465.
7. Lovestone S, Anderton B. Cytoskeletal abnormalities in Alzheimer's disease. Curr Opin Neurol Neurosurg 1992;5:883-888.
8. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease: amyloid A4 protein resembles a cell-surface receptor. Nature 1987;325:733-736.
9. Clarke R, Smith AD, Phil D, et al. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 1998;55:1449-1455.
10. Religa D, Stycz M, Peplonska B, et al. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord 2003;16:64-70.
11. Kluijtmans LA, Young IS, Boreham CA, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003;101:2483-2488.
12. Anello G, Gueant-Rodriguez RM, Bosco P, et al. Homocysteine and methylenetetrahydrofolate reductase polymorphism in Alzheimer's disease. Neuroreport 2004;15:859-861.
13. Ho PI, Ashline D, Dhitavat S, et al. Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Am J Clin Nutr 2003;61:560-565.
14. Zuliani G, Ble A, Zanca R, et al. Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia. Acta Neurol Scand 2001;103:304-308.
15. Brunelli T, Bagnoli S, Giusti B. The C677T methylenetetrahydrofolate reductase mutation is not associated with Alzheimer's disease. Neurosci Lett 2001;315:103-105.
16. Wakutani Y, Kowa H, Kusumi M, et al. Genetic analysis of vascular factors in Alzheimer's disease. Ann NY Acad Sci 2002;977:232-238.
17. McKahann G, Drachmann D, Folstein M. Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
18. Pfiffer CM, Huff DL, Gunter EW. Rapid and accurate HPLC assay dos pIAM total homocysteine and cysteine in a clinical laboratorysetting. Clin Chem 1999;454:290-292.
19. Frosst P, Pai A, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation at the methylenetetrahydro folate reductase locus. Nat Gen 1995; 10:110-113.
20. Skibola CF, Smith MY, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Rev PNAS 1999;96:12810-12815.
21. Esiri MM, Wilcock GK, Morris JH. Neuropathological assessment of the lesion of significance in vascular dementia. J Neurol Neurosurg Psychiatry 1997;63:749-753.
22. Bell IR, Edman JS, Selhub J, et al. Plasma homocysteine in nonvascular dementia of depressed elderly people. Acta Psychiatr Scand 1992;86:386-390.
23. Morris MS, Jacques PF, Rosenberg IH, et al. Hyperhomocysteinemia associated with poor recallin the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2001;73:927-933.
24. Seshadri S, Beiser, A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002;346:476-483.
25. Postiglione A, Milan G, Ruocco A, et al. Plasma folate, vitamin B12 and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylenetetrahydrofolate reductase gene in patients with Alzheimer's dementia. Gerontology 2001;47:324-329.
26. Selhub JL, Mlller JW The pathogenesis of homocysteinemia: interru ption of the coordinate regulation by S-adenosylmethionine of the remethylation and transulfuration of homocysteine. Am J Clin Nutr 1991;55:131-138.
27. Ulrich CM, Yasui Y, Storb R, et al. Pharmacogenetics of methothrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 2001;98:231-234.
28. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol 1998;147:30-35.
29. Pepe G, Venegas CO, Giusti B, et al. Heterogeneity in world distribution of the thermolabile C677T mutation in 5-10-methylenetetrahydrofolate reductase. Am J Hum Genet 1998;63:917-920.
30. Fernandez LL, Scheibe RM. Is MTHFR polymorphism a risk factor for Alzhimer's disease like APOE ? Arq Neuropsiquiatr 2005;63:1-6.
31. Prince JA, Feuk L, Gottfries J, et al. Lack of replication of association finings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-444.
32. Tysoe C, Galinsky D, Robinson D, et al. Analysis of alpha-1 antichymotrypsin, presenilin-1, angiotensin-converting enzyme, and methylenetetrahydrofolate reductase loci as candidates for dementia. Am J Med Genet 1997;74:207-212.
33. Kluijtmans LA, Kastelein JJ, Lindemans J, et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997;96:2573-2577.